Ethan Meltzer
Overview
Explore the profile of Ethan Meltzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wold J, Robertson J, Jeevarajan J, Knox M, Thatikunta P, Solorzano G, et al.
Neurohospitalist
. 2024 Nov;
:19418744241297187.
PMID: 39610897
The Neurohospitalist Core Competencies comprise a set of competency-based learning objectives that encapsulate the knowledge, skills, and attitudes of neurohospitalitists who specialize in the care of hospitalized patients with neurologic...
2.
Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variants
Berth S, Vo L, Kwon D, Grider T, Damayanti Y, Kosmanopoulos G, et al.
Brain
. 2024 Jul;
148(2):564-579.
PMID: 39021275
Dominant mutations in the calcium-permeable ion channel TRPV4 (transient receptor potential vanilloid 4) cause diverse and largely distinct channelopathies, including inherited forms of neuromuscular disease, skeletal dysplasias and arthropathy. Pathogenic...
3.
Meltzer E, Charron O, Wozny J, Onuorah H, Montague A, Kline A, et al.
Mult Scler Relat Disord
. 2023 Nov;
80:105085.
PMID: 37931487
Background: In the context of the COVID-19 pandemic, people with multiple sclerosis (pwMS) have been particularly vulnerable to adverse outcomes due to increased risk of severe infection and/or widespread disruptions...
4.
Galetta K, Meltzer E
J Neurol Sci
. 2023 Sep;
453:120804.
PMID: 37741773
Background And Objectives: This is an observational study of the performance of an artificial intelligence-powered chatbot tasked with solving unknown neurologic case vignettes. The primary objective of the study is...
5.
Sguigna P, Toranian S, Tardo L, Blackburn K, Horton L, Conger D, et al.
Mult Scler J Exp Transl Clin
. 2023 Mar;
9(1):20552173231159560.
PMID: 36936446
Background: Excessive daytime sleepiness (EDS) in multiple sclerosis (MS) can be a significant source of disability. Despite this, its prevalence as a patient-reported outcome in this condition has not been...
6.
Onuorah H, Charron O, Meltzer E, Montague A, Crispino A, Largent A, et al.
Neurology
. 2022 Jan;
98(9):e880-e892.
PMID: 35046135
Background And Objectives: Black and Hispanic people with multiple sclerosis (MS) (pMS) have been found to have different disease courses or worse outcomes associated with MS compared to White pMS....
7.
Cruz R, Chaudhary S, Guevara M, Meltzer E
Curr Rheumatol Rep
. 2021 Apr;
23(6):33.
PMID: 33909180
Purpose Of Review: To review the pathophysiology, presentation, and treatment of neuromyelitis optica spectrum disorder (NMOSD) and its association with systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). Recent Findings:...
8.
Cruz R, Hogan N, Sconzert J, Sconzert M, Major E, Lisak R, et al.
Neurol Neuroimmunol Neuroinflamm
. 2021 Jan;
8(1).
PMID: 33434885
No abstract available.
9.
Anadani N, Hyland M, Cruz R, Lisak R, Costello K, Major E, et al.
Neurol Neuroimmunol Neuroinflamm
. 2021 Jan;
8(1).
PMID: 33411672
No abstract available.
10.
Meltzer E, Campbell S, Ehrenfeld B, Cruz R, Steinman L, Parsons M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2020 Aug;
7(6).
PMID: 32769201
Objective: To determine whether the punctuated administration of low-dose rituximab, temporally linked to B-cell hyperrepopulation (defined when the return of CD19 B cells approximates 40%-50% of baseline levels as measured...